167 related articles for article (PubMed ID: 29849196)
1. The management of malignant pleural mesothelioma in the USA 2004-13-a decade of lost opportunity?
Waller DA
J Thorac Dis; 2018 Apr; 10(Suppl 9):S1044-S1046. PubMed ID: 29849196
[No Abstract] [Full Text] [Related]
2. Unexplained Pleural Effusion Leads to the Revelation of a Malignant Mesothelioma: A Case Report.
Rhazari M; Moueqqit O; Gartini S; El Morabit S; Diani S; Aharmim M; Thouil A; Kouismi H; El Bourkadi JE
Cureus; 2022 Apr; 14(4):e24478. PubMed ID: 35637829
[TBL] [Abstract][Full Text] [Related]
3. EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study.
Zauderer MG; Szlosarek PW; Le Moulec S; Popat S; Taylor P; Planchard D; Scherpereel A; Koczywas M; Forster M; Cameron RB; Peikert T; Argon EK; Michaud NR; Szanto A; Yang J; Chen Y; Kansra V; Agarwal S; Fennell DA
Lancet Oncol; 2022 Jun; 23(6):758-767. PubMed ID: 35588752
[TBL] [Abstract][Full Text] [Related]
4. Extended pleurectomy decortication for the treatment of malignant pleural mesothelioma.
Maat A; Durko A; Thuijs D; Bogers A; Mahtab E
Multimed Man Cardiothorac Surg; 2019 Nov; 2019():. PubMed ID: 31751008
[TBL] [Abstract][Full Text] [Related]
5. Malignant pleural mesothelioma: a new standard of care.
Stahel RA
Lung Cancer; 2006 Dec; 54 Suppl 2():S9-S14. PubMed ID: 17059852
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and pathological profile of the pleural malignant mesothelioma: A retrospective study about 30 cases].
Mlika M; Lamzirbi O; Limam M; Mejri N; Ben Saad S; Chaouch N; Ben Miled K; Marghli A; Mezni F
Rev Pneumol Clin; 2018 Dec; 74(6):427-435. PubMed ID: 30293912
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological characteristics and prognosis of malignant pleural mesothelioma].
Chen WH; Zhang XL; Dai HP; Tong ZH; Zhang YH; Jin ML
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):825-8. PubMed ID: 24507393
[TBL] [Abstract][Full Text] [Related]
8. Role of Prosaposin and Extracellular Sulfatase Sulf-1 Detection in Pleural Effusions as Diagnostic Biomarkers of Malignant Mesothelioma.
Zallocco L; Silvestri R; Ciregia F; Bonotti A; Marino R; Foddis R; Lucacchini A; Giusti L; Mazzoni MR
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359323
[TBL] [Abstract][Full Text] [Related]
9. Malignant cells from pleural fluids in malignant mesothelioma patients reveal novel mutations.
Sneddon S; Dick I; Lee YCG; Musk AWB; Patch AM; Pearson JV; Waddell N; Allcock RJN; Holt RA; Robinson BWS; Creaney J
Lung Cancer; 2018 May; 119():64-70. PubMed ID: 29656754
[TBL] [Abstract][Full Text] [Related]
10. Pleural-based mesothelioma in immune competent rats: a model to study adenoviral gene transfer.
Kucharczuk JC; Elshami AA; Zhang HB; Smythe WR; Hwang HC; Tomlinson JS; Amin KM; Litzky LA; Albelda SM; Kaiser LR
Ann Thorac Surg; 1995 Sep; 60(3):593-7; discussion 597-8. PubMed ID: 7677485
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma.
Moro J; Sobrero S; Cartia CF; Ceraolo S; Rapanà R; Vaisitti F; Ganio S; Mellone F; Rudella S; Scopis F; La Paglia D; Cacciatore CC; Ruffini E; Leo F
Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553016
[TBL] [Abstract][Full Text] [Related]
12. Near-Infrared Intraoperative Imaging Can Successfully Identify Malignant Pleural Mesothelioma After Neoadjuvant Chemotherapy.
Predina JD; Newton A; Kennedy G; Lee MK; Singhal S
Mol Imaging; 2017; 16():1536012117723785. PubMed ID: 28856921
[TBL] [Abstract][Full Text] [Related]
13. Mesothelioma in situ with regressive malignant pleural effusion and an unexpected evolution: A case report.
Almeida GC; Santos UP; Parente YDM; Colares PFB; Mizutani RF; Bernardi FDC; Terra RM; Terra-Filho M
Am J Ind Med; 2022 Jul; 65(7):620-623. PubMed ID: 35524457
[TBL] [Abstract][Full Text] [Related]
14. Repurposing therapeutics for malignant pleural mesothelioma (MPM) - Updates on clinical translations and future outlook.
Kulkarni NS; Gupta V
Life Sci; 2022 Sep; 304():120716. PubMed ID: 35709894
[TBL] [Abstract][Full Text] [Related]
15. A Narrative Review-Management of Malignant Pleural Effusion Related to Malignant Pleural Mesothelioma.
Qureshi M; Thapa B; Muruganandan S
Heart Lung Circ; 2023 May; 32(5):587-595. PubMed ID: 36925448
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy for malignant pleural mesothelioma.
Chapman E; Berenstein EG; Diéguez M; Ortiz Z
Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD003880. PubMed ID: 16856023
[TBL] [Abstract][Full Text] [Related]
17. Malignant pleural mesothelioma: the standard of care and challenges for future management.
van Meerbeeck JP; Scherpereel A; Surmont VF; Baas P
Crit Rev Oncol Hematol; 2011 May; 78(2):92-111. PubMed ID: 20466560
[TBL] [Abstract][Full Text] [Related]
18. Management of Pleural Effusion Secondary to Malignant Mesothelioma.
Musso V; Diotti C; Palleschi A; Tosi D; Aiolfi A; Mendogni P
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575358
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Measurement of Pleural Fluid Biochemistry and Cytokines in Malignant Pleural Effusions.
Thomas R; Cheah HM; Creaney J; Turlach BA; Lee YC
Chest; 2016 Jun; 149(6):1494-500. PubMed ID: 26836920
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma.
Steele JP; O'Doherty CA; Shamash J; Evans MT; Gower NH; Tischkowitz MD; Rudd RM
Ann Oncol; 2001 Apr; 12(4):497-9. PubMed ID: 11398882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
